Topical Isotretinoin (TMB-001) Treatment for 12 Weeks Did Not Result in Clinically Relevant Laboratory Abnormalities in Participants with Congenital Ichthyosis in the Phase 2b CONTROL Study
在 2b 期 CONTROL 研究中,接受为期 12 周的局部异维A酸 (TMB-001) 治疗的先天性鱼鳞病患者未出现具有临床意义的实验室异常。
期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-023-00923-1
Marathe, Kalyani; Teng, Joyce M C; Guenthner, Scott; Bunick, Christopher G; Kempers, Steven; Eads, Kimmie; Castelo-Soccio, Leslie; Mendelsohn, Alan M; Raiz, Jessica; Murrell, Dédée F